Jaundice and its management through Ayurved

A clinical Study of Devdali Hima Nasya and Dronpushpi Swarasa Anjana in the Management of Kamala roga w.s.r to Jaundice

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031129

Enrollment

Registered

2021-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R17- Unspecified jaundice

Interventions

Intervention1: Nasya, Anjana: GROUP A- nasya with devdali hima(2 bindu in each nostrils for one month once a week) GROUP B- anjana with dronpushpi swarasa(2 ml for one month once a week) Control Inte

Eligibility

Inclusion criteria

Inclusion criteria: Apparently normal patient of kamala roga(jaundice) with no serious life threatening complication.

Exclusion criteria

Exclusion criteria: [1]Acute or chronic diarrhea disorder. [2]Bleeding, piles, prolapse of rectum and other anorectal surgical condition. [3] serious infections like typhoid, tuberculosis.etc [4] malignancy [5]excessive weak, and dehydrated condition. [6] metabolic disorders like diabetes mellitus, thyroid dysfunction etc. [7]serious cardiovascular disorders. [8]cirrhosis with portal hypertension. [9]peptic ulcer. [10]Any other conditions in which virechana is contraindicated.

Design outcomes

Primary

Measure	Time frame
Improvement in Subjective and Objective ParametersTimepoint: 30 days	—

Secondary

Measure	Time frame
To find out the comparative Efficacy of the Treatment in both the groupsTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Rekha kanwar

DSRRAU ,Jodhpur

drmksharma2016@gmail.com9829695452

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026